These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36891473)

  • 41. [L-dopa/benserazide during pregnancy in a patient with juvenile parkinsonism].
    Arai H; Shinotoh H; Hattori T
    Rinsho Shinkeigaku; 1997 Mar; 37(3):264-5. PubMed ID: 9217430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with monogenic PRKN and LRRK2 forms of Parkinson's disease.
    Prendes Fernández P; Blázquez Estrada M; Sol Álvarez J; Álvarez Martínez V; Suárez San Martín E; García Fernández C; Álvarez Carriles JC; Lozano Aragoneses B; Saiz Ayala A; Santamarta Liébana E; González Álvarez L
    Parkinsonism Relat Disord; 2023 Feb; 107():105282. PubMed ID: 36657280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
    Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.
    Oczkowska A; Kozubski W; Lianeri M; Dorszewska J
    Curr Genomics; 2013 Dec; 14(8):502-17. PubMed ID: 24532983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
    Abbas N; Lücking CB; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan JR; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi BS; Oostra BA; Fabrizio E; Böhme GA; Pradier L; Wood NW; Filla A; Meco G; Denefle P; Agid Y; Brice A
    Hum Mol Genet; 1999 Apr; 8(4):567-74. PubMed ID: 10072423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Han Chinese Family With Early-Onset Parkinson's Disease Carrying Novel Frameshift Mutation and Compound Heterozygous Mutation of
    Gao C; Huang T; Chen R; Yuan Z; Tian Y; Zhang Y
    Front Neurol; 2020; 11():582323. PubMed ID: 33154736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-218 Inhibits Mitochondrial Clearance by Targeting PRKN E3 Ubiquitin Ligase.
    Di Rita A; Maiorino T; Bruqi K; Volpicelli F; Bellenchi GC; Strappazzon F
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of a human iPSC line CIBi007-A from a patient with young-onset Parkinson's disease carrying variants in PRKN and HTRA2.
    Yan Y; Wu S; Jiang L; Yang B; Chen X; Liu Y; Yu B; Fu J; Yu J; Ning H; Chu M; Yang J
    Stem Cell Res; 2020 Jul; 47():101905. PubMed ID: 32688332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
    Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
    J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?
    Merola A; Zibetti M; Artusi CA; Marchisio A; Ricchi V; Rizzi L; Angrisano S; Arduino N; Lanotte M; Rizzone M; Lopiano L
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):251-7. PubMed ID: 22180646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent.
    Hu J; Waters CH; Spiegelman D; Fon EA; Yu E; Asayesh F; Krohn L; Saini P; Alcalay RN; Hassin-Baer S; Gan-Or Z; Krainc D; Zhang B; Bustos BI; Lubbe SJ;
    Neurobiol Aging; 2022 Nov; 119():136-138. PubMed ID: 36305379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson's Disease.
    Salemi M; Lanza G; Salluzzo MG; Schillaci FA; Di Blasi FD; Cordella A; Caniglia S; Lanuzza B; Morreale M; Marano P; Tripodi M; Ferri R
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deep Brain Stimulation and Treatment Outcomes of Young- and Late-Onset (≤55 Years) Parkinson's Disease: A Population-Based Study.
    Camerucci E; Stang CD; Turcano P; Tipton PW; Bower JH; Hassan A; Klassen BT; Savica R
    Front Neurol; 2021; 12():784398. PubMed ID: 34956065
    [No Abstract]   [Full Text] [Related]  

  • 54. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.
    Niu K; Fang H; Chen Z; Zhu Y; Tan Q; Wei D; Li Y; Balajee AS; Zhao Y
    Autophagy; 2020 Apr; 16(4):724-734. PubMed ID: 31432739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of head trauma and sport participation in young-onset Parkinson's disease.
    Schirinzi T; Grillo P; Di Lazzaro G; Zenuni H; Salimei C; Dams-O'Connor K; Sancesario GM; Mercuri NB; Pisani A
    J Neural Transm (Vienna); 2021 Aug; 128(8):1185-1193. PubMed ID: 34263354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Better quality of life and less caregiver strain in young-onset Parkinson's disease: a multicentre retrospective cohort study.
    Te Groen M; Bloem BR; Wu SS; Post B;
    J Neurol; 2021 Mar; 268(3):1102-1109. PubMed ID: 33108538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expanding the canvas of PRKN mutations in familial and early-onset Parkinson disease.
    Pandey S; Tomar LR; Kumar S; Dinesh S; Thelma BK
    Parkinsonism Relat Disord; 2019 Sep; 66():216-219. PubMed ID: 31409571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ubiquitin E3 ligase Parkin regulates neuronal Ca
    Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R
    J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease.
    Isonaka R; Goldstein DS; Zhu W; Yoon E; Ehrlich D; Schindler AB; Kokkinis AD; Sabir MS; Scholz SW; Bandres-Ciga S; Blauwendraat C; Gonzalez-Alegre P; Lopez G; Sidransky E; Narendra DP
    Mov Disord; 2021 Oct; 36(10):2346-2357. PubMed ID: 34076298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Compound Heterozygous
    Fan K; Hu P; Song C; Deng X; Wen J; Liu Y; Deng H
    Parkinsons Dis; 2019; 2019():9024894. PubMed ID: 31929871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.